Arcturus Therapeutics logo

Arcturus Therapeutics

ARCT | NASDAQ
Chart Builder DCF Calculator
$8.31
-$0.05 (-0.60%)
At close: Nov 16, 2026, 4:00 PM ET
$8.31
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.60%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
39.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #539/1021 (Top 53%)

Key Statistics

Market Data

Market Cap $239.51M
1D Range
8.28 9.78
52W Range
5.53 16.93

Valuation (TTM)

PE -2.68
PB 1.42
EV/EBITDA -0.93

Valuation (NTM)

Forward PE N/A
Forward PEG -0.06
Price Target $30.50
Loading financial charts...

Profile

Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respira...

Sector Healthcare
Industry Biotechnology
Employees 109
IPO Date May 22, 2013
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.26
Beat +62.13%
REV
$18.3M
Beat +128.80%
Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$30.50
Upside
+267.03%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.